Change in NVRL Hepatitis E screening: UPDATE to be introduced 28th November 2022

Printer-friendly versionPrinter-friendly version

NVRL is replacing the Fortress HEV IgM assay in favour of Diasorin Liaison XL HEV IgM assay and also introducing a supplementary second line Vidas HEV IgM assay to confirm Diasorin reactive samples.

The Diasorin and Vidas HEV IgM assays have comparable sensitivity. However, by using two assays in combination, we can generate improved specificity in comparison with Fortress HEV IgM alone, whilst also allowing for increased automation.

NVRL IT department will provide specific information including relevant test request codes.

Please contact 01-7164401 if you wish to discuss this matter further.

This change is effective from November 28th 2022.

Reference: CN-22-20